Citations

Mayo Clinic

Showing 10 of 108523 citations.

Late Onset Ipilimumab-Induced Pericarditis and Pericardial Effusion: A Rare but Life Threatening Complication
Mansour, Iyad , Hariri, Dana , Motamed, Sara , Yun, Seongseok , Vincelette, Nicole D. , Yun, Seongseok

Case Reports in Oncological Medicine | March 31, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-5

10.1155/2015/794842 | PMID 25918658 Get It

Metastatic cutaneous melanoma has poor prognosis with 2-year survival rate of 10–20%. Melanoma cells express various antigens including gp100, melanoma antigen recognized by T cells 1 (MART-1), and tyrosinase, which can induce immune-mediated anticancer response via T cell activation. Cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) is an immune check point molecule that negatively regulates T cell activation and proliferation. Accordingly, recent phase III clinical trials demonstrated significant survival benefit with ipilimumab, a human monoclonal antibody (IgG1) that blocks the interaction of CTLA-4 with its ligands. Since the efficacy of ipilimumab depends on T cell activation, it is associated with substantial risk of immune mediated adverse reactions such as colitis, hepatitis, thyroiditis, and hypophysitis. We report the first case of late onset pericarditis and cardiac tamponade associated with ipilimumab treatment in patient with metastatic cutaneous melanoma.
Expression of Polarity Genes in Human Cancer
Lin, Wan-Hsin, Asmann, Yan W. , Anastasiadis, Panos Z. , Lin, Wan‐Hsin

Cancer Informatics | March 31, 2015 | Volume: 14s3 | Issue: No issue available | Pages: CIN.S18964

10.4137/cin.s18964 | PMID 25991909 Get It

Polarity protein complexes are crucial for epithelial apical-basal polarity and directed cell migration. Since alterations of these processes are common in cancer, polarity proteins have been proposed to function as tumor suppressors or oncogenic promoters. Here, we review the current understanding of polarity protein functions in epithelial homeostasis, as well as tumor formation and progression. As most previous studies focused on the function of single polarity proteins in simplified model systems, we used a genomics approach to systematically examine and identify the expression profiles of polarity genes in human cancer. The expression profiles of polarity genes were distinct in different human tissues and classified cancer types. Additionally, polarity expression profiles correlated with disease progression and aggressiveness, as well as with identified cancer types, where specific polarity genes were commonly altered. In the case of Scribble, gene expression analysis indicated its common amplification and upregulation in human cancer, suggesting a tumor promoting function.
The prevalence of substance use disorders in American physicians
Oreskovich, Michael R., Sotile, Wayne M., Satele, Daniel , Sloan, Jeff, Boone, Sonja, Shanafelt, Tait D. , Dyrbye, Liselotte N. , Tan, Litjen , West, Colin P. , Sloan, Jeff A.

The American Journal on Addictions | March 30, 2015 | Volume: 24 | Issue: 1 | Pages: 30-38

10.1111/ajad.12173 | PMID 25823633 Get It

Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease
Toledo, Jon B. , Bjerke, Maria , Da, Xiao , Landau, Susan, Foster, Norman L. , Jagust, William, Jack, Clifford R. , Weiner, Michael W. , Davatzikos, Christos , Shaw, Leslie M. , Trojanowski, John Q. , Hsiung, Ging‐Yuek Robin , Preda, Adrian , Jicha, Gregory A. , Ponto, Laura L. Boles , Jack, Clifford R , Preda, Adrian , Hsiung, Gink-Yuek , Jicha, Gregory A

JAMA Neurology | March 30, 2015 | Volume: 72 | Issue: 5 | Pages: 571

10.1001/jamaneurol.2014.4829 | PMID 25822737 Get It

Incidence and impact of postoperative atrial fibrillation after minimally invasive esophagectomy
Day, Ryan W. , Jaroszewski, Dawn E. , Ross, Helen J. , Paripati, Harshita, Ashman, Jonathan B. , Rule, William G., Harold, Kristi L., Chang, Yu‐Hui

Diseases of the Esophagus | March 30, 2015 | Volume: 29 | Issue: 6 | Pages: 583-588

10.1111/dote.12355 | PMID 25824527 Get It

Response‐adapted therapy for aggressive non‐Hodgkin's lymphomas based on early [18F] FDG‐PET scanning: ECOG‐ACRIN Cancer Research Group study (E3404)
Swinnen, Lode J., Li, Hailun , Quon, Andrew , Gascoyne, Randy D. , Ranheim, Erik A. , Horning, Sandra J., Advani, Ranjana H. , Hong, Fangxin , Habermann, Thomas M. , Kahl, Brad S. , Advani, Ranjana H

British Journal of Haematology | March 30, 2015 | Volume: 170 | Issue: 1 | Pages: 56-65

10.1111/bjh.13389 | PMID 25823885 Get It

Summary A persistently positive positron emission tomography ( PET ) scan during therapy for diffuse large B‐cell lymphoma ( DLBCL ) is predictive of treatment failure. A response‐adapted strategy consisting of an early treatment change to four cycles of R‐ ICE (rituximab, ifosfamide, carboplatin, etoposide) was studied in the Eastern Cooperative Oncology Group E3404 trial. Previously untreated patients with DLBCL stage III, IV, or bulky II, were eligible. PET scan was performed after three cycles of R‐ CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and scored as positive or negative by central review during the fourth cycle. PET ‐positive patients received four cycles of R‐ ICE , PET ‐negative patients received two more cycles of R‐ CHOP . A ≥45% 2‐year progression‐free survival ( PFS ) for mid‐treatment PET ‐positive patients was viewed as promising. Of 74 patients, 16% were PET positive, 79% negative. The PET positivity rate was much lower than the 33% expected. Two‐year PFS was 70%; 42% [90% confidence interval (CI), 19–63%] for PET ‐positives and 76% (90% CI 65–84%) for PET ‐negatives. Three‐year overall survival ( OS ) was 69% (90% CI 43–85%) and 93% (90% CI 86–97%) for PET ‐positive and ‐negative cases, respectively. The 2‐year PFS for mid‐treatment PET ‐positive patients intensified to R‐ ICE was 42%, with a wide confidence interval due to the low proportion of positive mid‐treatment PET scans. Treatment modification based on early PET scanning should remain confined to clinical trials.
Brain-derived neurotrophic factor
Benarroch, Eduardo E.

Neurology | March 29, 2015 | Volume: 84 | Issue: 16 | Pages: 1693-1704

10.1212/wnl.0000000000001507 | PMID 25817841 Get It

Does Relief from Intra-articular Anesthetic Injection Predict Outcome after Hip Arthroscopy?
Engasser, William M. , Sousa, Paul L., King, Alexander H. , Levy, Bruce A. , Krych, Aaron J. , Sierra, Rafael J.

Orthopaedic Journal of Sports Medicine | March 29, 2015 | Volume: 3 | Issue: 3_suppl | Pages: No page available

10.1177/2325967115s00018 Get It

Objectives: Intra-articular (IA) anesthetic injection is commonly performed as a diagnostic test in the setting of femoroacetabular impingement (FAI). Currently, there is a paucity of data correlating post-injection pain relief and outcomes after hip arthroscopy for FAI. The purpose of this study is to determine whether the amount of pain relief after IA injection predicts clinical and functional outcomes following hip arthroscopy. We hypothesize that increased pain relief (>50%) will correlate with better outcomes after surgery. Methods: The records of patients undergoing hip arthroscopy for FAI at our institution between April 2007 and April 2012 were reviewed. We identified patients who underwent IA injection and subsequent hip arthroscopy. Inclusion criteria were: ultrasound or fluoroscopic guided intra-articular anesthetic injection performed at our institution, prospectively documented pre- and post-injection Numerical Rating Scale (NRS) pain scores, no prior ipsilateral hip surgery, and minimum 1 year follow-up. Pre-operative radiographs were reviewed and degree of osteoarthritis was determined using the Tonnis classification system. Outcomes were assessed with Modified Harris Hip Score (MHHS) and Hip Outcome Score (HOS). Univariate and multivariate models were performed to assess whether percent pain relief correlated with outcome scores. Results: 99 hips in 96 patients met our inclusion criteria and included 71 females (74%) and 25 males (26%) with a mean age of 37.5 ± 14.0 years. 26 patients had Tonnis grade 0, 55 had grade 1, and 18 had grade 2 (0 grade 3). Mean pain relief after IA injection was 73.6 ± 36.1 (range 0-100) percent. 26 patients (26%) had ≤50% pain relief while 73 (74%) had >50% pain relief. Outcome scores were obtained at a mean 14.9 months. Mean MHHS, HOS-ADL, and HOS-Sport scores were 79.2 ± 17.3, 82.6 ± 17.3, and 67.4 ± 28.2, respectively. There was no statistical correlation between percent pain relief and MHHS, HOS-ADL, or HOS-Sport scores. There was no significant difference in outcome scores between those with ≤50% and >50% pain relief. While patients that received >50% pain relief by IA injection were more likely to achieve positive results (MHHS >70) with a likelihood ratio of 1.23 (95% CI 0.92-1.53), this was not significant. Multivariate regression analysis demonstrated no significant predictors of outcome, including age, gender, Tonnis grade, percent relief with IA injection, number of months postoperatively, or type of surgery. Conclusion: In patients undergoing hip arthroscopy for FAI, our data indicates that the amount of pain relief from IA injection is a poor predictor of short term outcome, even when adjusting for chondral degeneration. While anesthetic injections can be an important diagnostic tool in select patients, correlation of the clinical history, physical examination, and imaging findings are fundamental. In addition, outcome following hip arthroscopy remains multifactorial.
Treatment for Acquired Apraxia of Speech: A Systematic Review of Intervention Research Between 2004 and 2012
Ballard, Kirrie J. , Layfield, Claire, Maas, Edwin , Mauszycki, Shannon C. , McNeil, Malcolm R. , Wambaugh, Julie L. , Duffy, Joseph R.

American Journal of Speech-Language Pathology | March 28, 2015 | Volume: 24 | Issue: 2 | Pages: 316-337

10.1044/2015_ajslp-14-0118 | PMID 25815778 Get It

Objectives The aim was for the appointed committee of the Academy of Neurological Communication Disorders and Sciences to conduct a systematic review of published intervention studies of acquired apraxia of speech (AOS), updating the previous committee's review article from 2006. Method A systematic search of 11 databases identified 215 articles, with 26 meeting inclusion criteria of (a) stating intention to measure effects of treatment on AOS and (b) data representing treatment effects for at least 1 individual stated to have AOS. Results All studies involved within-participant experimental designs, with sample sizes of 1 to 44 (median = 1). Confidence in diagnosis was rated high to reasonable in 18 of 26 studies. Most studies (24/26) reported on articulatory–kinematic approaches; 2 applied rhythm/rate control methods. Six studies had sufficient experimental control for Class III rating according to the Clinical Practice Guidelines Process Manual (American Academy of Neurology, 2011), with 15 others satisfying all criteria for Class III except use of independent or objective outcome measurement. Conclusions The most important global clinical conclusion from this review is that the weight of evidence supports a strong effect for both articulatory–kinematic and rate/rhythm approaches to AOS treatment. The quantity of work, experimental rigor, and reporting of diagnostic criteria continue to improve and strengthen confidence in the corpus of research.
Induction and functional significance of the heme oxygenase system in pathological shear stress in vivo
Lu, Kang , Hillestad, Matthew L. , Grande, Joseph P. , Croatt, Anthony J., Barry, Michael A. , Farrugia, Gianrico , Katušić, Zvonimir S. , Nath, Karl A. , Kang, Lu, Barry, Michael A

American Journal of Physiology-Heart and Circulatory Physiology | March 28, 2015 | Volume: 308 | Issue: 11 | Pages: H1402-H1413

10.1152/ajpheart.00882.2014 | PMID 25820397 Get It

The present study examined the heme oxygenase (HO) system in an in vivo murine model of pathological shear stress induced by partial carotid artery ligation. In this model, along with upregulation of vasculopathic genes, HO-1 is induced in the endothelium and adventitia, whereas HO-2 is mainly upregulated in the endothelium. Within minutes of ligation, NF-κB, a transcription factor that upregulates vasculopathic genes and HO-1, is activated. Failure to express either HO-1 or HO-2 exaggerates the reduction in carotid blood flow and exacerbates vascular injury. After artery ligation, comparable induction of HO-2 occurred in HO-1+/+and HO-1−/−mice, whereas HO-1 induction was exaggerated in HO-2−/−mice compared with HO-2+/+mice. Upregulation of HO-1 by an adeno-associated viral vector increased vascular HO-1 expression and HO activity and augmented blood flow in both ligated and contralateral carotid arteries. Acute inhibition of HO activity decreased flow in the ligated carotid artery, whereas a product of HO, carbon monoxide (CO), delivered by CO-releasing molecule-3, increased carotid blood flow. In conclusion, in the partial carotid artery ligation model of pathological shear stress, this study provides the first demonstration of 1) upregulation and vasoprotective effects of HO-1 and HO-2 and the vasorelaxant effects of CO as well as 2) vascular upregulation of HO-1 in vivo by an adeno-associated viral vector that is attended by a salutary vascular response. Induction of HO-1 may reside in NF-κB activation, and, along with induced HO-2, such upregulation of HO-1 provides a countervailing vasoprotective response in pathological shear stress in vivo.